Cradle
Agent44 out of 100, Above median. Agent Readiness. Open the scores section.Agent Readiness: 44/100. Above median. Measured by StartupHub.ai. Median 41.Trust85 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 85/100. Top 25%. Measured by StartupHub.ai. Median 61.Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
About
Cradle Bio B.V. is a Dutch-Swiss biotechnology company that develops software using machine learning for protein engineering. Their platform accelerates the discovery and development of proteins by enabling faster engineering processes, reducing experimental rounds, and optimizing multiple objectives simultaneously.
Listed competitors
AI-driven biotechnology company developing novel protein therapeutics through generative biology.
Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.
Also in this space
AI-powered materials science and discovery platform to accelerate scientific breakthroughs.
Shares Artificial Intelligence, Drug Discovery
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.
Shares Biotech, AI-Driven Protein Design
Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.
Shares Biotech, Drug Discovery
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.
Shares Biotech, Drug Discovery
Public companies
Cradle and Recursion both leverage AI and machine learning for drug discovery and protein engineering, aiming to accelerate the development of new therapeutics.
Competing product: Recursion OS
While Twist Bioscience focuses on synthetic DNA, Cradle's protein engineering platform could be seen as a complementary or alternative approach for companies seeking to design and optimize biological molecules for various applications.
Competing product: Twist Bioscience platform
Key facts
- Website
- cradle.bio
- Headquarters
- Amsterdam, Netherlands
- Founded
- 2021
- Employees
- 112
- Total funding
- $102M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 26 Nov 2024 | Series B | $73M | IVP |
| 28 Nov 2023 | Series A | $24M | Index Ventures |
| 17 Nov 2022 | Seed | $5M | Index Ventures |
Tech stack
Detected on cradle.bio, last scanned 8 Nov 2026. Run your own scan
- CMS / Builders
- Framer, Squarespace
- Email provider
- Google Workspace
- Status page
- BetterStack
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
What does Cradle do?
They serve industries such as pharmaceuticals, chemicals, food, and agriculture.
Is Cradle trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Cradle is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Cradle raised?
Cradle has raised a total of $102M in funding. The most recent round on record is Series B.
How many employees does Cradle have?
Cradle has approximately 112 people on record.
A global leader in healthcare, developing innovative solutions for consumer health, pharmaceuticals, and medical devices.
Biopharma
Novonesis is a global biosolutions company that leverages microbiology and science to transform industries like food, beverages, household care, and bioenergy.
Industrial Biotechnology
A global biopharmaceutical company dedicated to advancing brain health through the research, development, and commercialization of treatments for neurological and psychiatric disorders.
Pharmaceuticals
Confirmed customers of Cradle.
SEC filings, insider activity, nonprofit links and pay benchmarks for Cradle:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
